Report Archive
All Research
Page 1 of 43 · 1027 reports
65/100
Alphabet: Search and Cloud Are Both Accelerating, but a 200 Billion Dollar Build Has Turned Free Cash Flow Negative and 333.68 Dollars Already Prices In the Base Case
Alphabet is a global internet platform whose high-intent Search advertising funds YouTube, Google Cloud and a frontier AI infrastructure build; FY2025 revenue was 402.8 billion USD. Second-quarter 2026 revenue grew 24% to 119.8 billion USD and Cloud grew 82% to 24.8 billion USD at a 35.6% operating margin on a 514 billion USD backlog, yet capital expenditure of 44.9 billion USD exceeded operating cash flow and produced negative free cash flow of 5.9 billion USD, with FY2026 guidance raised to 195 to 205 billion USD. Rating Hold: on roughly 130 billion USD of estimated owner earnings the shares trade near 31 times rather than the reported 16.8 times, so 333.68 USD sits at the 335 USD base intrinsic value with no conservative margin of safety.
57/100
TSMC: Earnings Have Outrun the Share Price to a 28.1x Trailing Multiple, but a Limit-Up Close at NT$2,425 Leaves Only a Limited Margin of Safety
The world's largest pure-play semiconductor foundry, monetizing process technology, manufacturing scale and customer trust across advanced logic and packaging, with high-performance computing at 66% of Q2 revenue and 7-nanometer-and-below nodes at 77% of wafer revenue. Since the 2026-05-22 edition the ordinary share rose 8.5% while trailing EPS rose about 16.0%, compressing the trailing P/E from roughly 30.0 to 28.1 times, though almost the entire move arrived in one 9.98% limit-up session on the base date. Rating Hold: earnings have outrun the price, but the current quote lacks a conservative margin of safety against margin and geopolitical tail risk.
40/100
Resonac Holdings: 99.3% of Core Operating Profit Now Comes From Semiconductor Materials, but at ¥12,125 the Pre-Spin Package Offers No Discount to Conservative Value
Resonac Holdings is a diversified Japanese materials group whose semiconductor and electronic materials segment, supplying die-bonding films, epoxy molding compounds and copper-clad laminates for advanced chip packaging alongside front-end CMP slurries, produced 99.3% of FY2025 core operating profit on 37.6% of consolidated sales. FY2025 core operating profit rose 18.4% to ¥109.1 billion while reported operating profit fell 47.6% to ¥46.7 billion, and FY2026 guidance for ¥140 billion core and ¥105 billion reported depends on narrowing that ¥62.5 billion gap to ¥35 billion. Rating Hold: at ¥12,125 the pre-spin package, one Resonac share plus the entitlement to one Crasus Chemical share, sits inside the ¥10,200 to ¥13,800 fair zone with no discount to conservative value.
31/100
Diageo: Cyclical Trough and Structural Erosion Are Both Real, and at 16.435 Pounds the Discount Is Not Yet Wide Enough
Diageo is a global spirits and beer owner whose Johnnie Walker, Guinness, Don Julio and Smirnoff franchises rest on brand investment, distribution scale and aged liquid that cannot be recreated quickly. Spirits supplied about 76% of FY2025 net sales of US$20.2 billion and beer 18%, but North America alone produced US$3.05 billion of operating profit before exceptional items, roughly 54% of the group total, so weak US spirits demand outweighs strength in Guinness, Europe and Africa. Rating Hold: the franchises and the cash flow are intact, but net debt of US$21.7 billion at 3.4 times EBITDA and a price sitting inside the 15.70 to 21.00 pound fair zone leave the ideal buy zone down at 11.50 to 12.50 pounds.
45/100
ASMPT: Record Bookings and a Real TCB Inflection, but at 135.10 HKD There Is No Conservative-Case Margin of Safety
ASMPT supplies back-end semiconductor packaging and electronics-assembly equipment through two segments, with its earnings mix shifting toward thermo-compression bonding and other advanced-packaging tools. First-half 2026 bookings rose 85.1% to HK$12.75 billion for a book-to-bill of 1.43 and adjusted gross margin reached 41.2%, but 2025 operating cash flow was only HK$243 million and the HBM4 opportunity remains at qualification rather than volume production. Rating Hold: the bookings inflection and SEMI margin recovery are real, yet at HK$135.10 the shares sit above the HK$108 conservative value and offer no margin of safety.
48/100
Hanwha Aerospace: The K9 Export Franchise Is Genuine, but at 865,000 KRW the Price Still Rides on Backlog Conversion and Capital Discipline
Hanwha Aerospace is a Korean land-defense exporter whose K9 howitzer and Chunmoo rocket-artillery franchises now fund a wider aerospace-and-shipbuilding group. Land defense turned KRW 8.13 trillion of 2025 revenue into KRW 2.01 trillion of operating profit, a 24.7% margin, while aerospace earned only KRW 2.3 billion on KRW 2.51 trillion of revenue and Hanwha Ocean supplied nearly half of consolidated sales, making the 138% headline revenue growth largely a consolidation effect. Rating Hold: the installed base behind the KRW 39.7 trillion backlog is real, but at KRW 865,000 the stock still sits above the KRW 700,000 conservative value, leaving the ideal buy zone at KRW 500,000 to 560,000.
50/100
Procore Technologies: Operating Leverage Finally Shows, but a 16%-of-Revenue Stock-Compensation Bill Leaves 48.82 USD Fairly Priced Rather Than Cheap
Procore is the leading construction-management SaaS platform, pricing subscriptions by product mix and annual construction volume rather than by seat. Q2 2026 revenue rose 15.8% to 375.2 million USD with a 21.5% non-GAAP operating margin, yet stock compensation at 16.1% of revenue holds GAAP operating margin at just 1.2%. Rating Hold: real operating leverage arriving at a fair price, with the ideal buy band at 34–36 USD.
39/100
NexGen Energy: The Licence Is In Hand, and at 8.93 USD the Price Already Assumes the Mine Gets Built
NexGen Energy is a pre-revenue Canadian uranium developer whose entire case rests on Rook I, an Athabasca Basin project designed for 30 million pounds of U₃O₈ a year at peak. The March 2026 CNSC licence cleared the binary permitting risk, but pre-production capital has already moved from C$1.30 billion to about C$2.2 billion and the definitive project-debt package is still not public. Rating Watch: a world-class orebody priced at US$8.93 for a mine that does not exist yet, with the ideal buy range at 3.7 to 4.6 USD.
36/100
Kinross Gold: A Gold-Levered Cash Machine in Transition, but at 23.50 USD the Unresolved Cost Gap Leaves No Margin of Safety
Kinross Gold is a senior gold producer with mines in the United States, Brazil, Chile and Mauritania, plus the Great Bear development project in Ontario. Second-quarter 2026 attributable free cash flow of 726.8 million dollars came mainly from a realized gold price of 4,483 dollars an ounce rather than from cost control, as attributable AISC rose to 1,821 dollars against reaffirmed full-year guidance of about 1,730. Rating Hold: net cash near 1.92 billion dollars and a real Ontario growth option are offset by gold dependence and an unproven second-half cost bridge, and at 23.50 USD the shares sit inside the acceptable-hold band with no margin of safety.
38/100
Parsons: A Record 35% Crash Repriced Earnings Quality, and at 40.32 USD the Price Is Interesting but Not Yet Safe
Parsons is a US federal technology and critical infrastructure contractor, pairing defense and intelligence work for the US government with transportation and infrastructure programs concentrated in the Middle East. Second-quarter 2026 revenue was flat at $1.576bn and the reported adjusted EBITDA margin fell to 2.7%, normalizing to 10.1% only after $77.5m of remote-program losses and a $40.9m legacy JV charge, while management cut midpoint full-year adjusted EBITDA guidance by 17.8%. Rating Watch: the franchises and the $9.26bn backlog are real, but after a record 35.0% single-day crash the $40.32 price still sits above the $31 to $34 ideal buy zone.
58/100
TeraWulf: Lake Mariner Is a Real Scarce-Power Campus, but at 15.09 USD the Price Already Assumes Substantial Execution Success
TeraWulf is a former bitcoin miner turning Lake Mariner, a retired coal-plant site in Western New York, into a contracted AI/HPC campus leased to Fluidstack with Google credit support. HPC leasing became the majority of revenue for the first time in the March 2026 quarter at 21.0 million dollars, but the 6.7 billion dollar headline contract value compresses hard against build costs of 8 to 10 million dollars per MW, 3.2 billion dollars of Lake Mariner secured notes and roughly 819 million reserved shares. Rating Watch: the campus and the contracts are real, yet at 15.09 USD the price already sits above the 9 USD value implied by the conservative scenario.
46/100
BAE Systems: The Portfolio Moat Is Genuine, but at 20.27 GBP the Rerating Has Already Outrun Earnings Growth
BAE Systems is a UK-listed defence prime with a more American revenue base than the label suggests, spanning combat air, electronic systems, submarines, land systems and cyber. FY2025 sales reached 30.7 billion pounds with underlying EBIT of 3.322 billion and a 10.8% group return on sales, yet the 83.6 billion headline backlog shrinks to 63.1 billion on the stricter IFRS measure and segment margins run from 15.4% in Electronic Systems down to 6.7% in Maritime. Rating Hold: the breadth and the demand cycle are genuine, but at 20.27 pounds the stock trades on about 24.5 times forward earnings with a 3.6% free cash flow yield against 5.0% gilts, leaving the ideal buy zone at 12.00 to 14.50 pounds.
55/100
AMD: The Rack-Scale AI Story Got More Credible, but 495 USD Already Prices Durable Number-Two Platform Status
AMD is a fabless designer whose profit engine has shifted to data-center CPUs and AI accelerators, and it is now trying to become the open, rack-scale second source for frontier AI infrastructure. Helios, the disclosed up-to-6-gigawatt Meta framework and named Microsoft, Oracle and OpenAI engagements make that ambition far more credible than it was in May, yet 2025 revenue of 34.6 billion USD and net income of 4.335 billion USD leave the stock at roughly 23 times sales and 186 times trailing earnings. Rating Avoid: the platform transition is real, but at 494.95 USD the margin of safety is zero and the ideal buy zone sits at 175 to 208 USD.
48/100
Saint-Gobain: A Higher Margin Floor Is Proven, but at 74.16 EUR the Price Sits Above the 64 EUR Conservative Value
Saint-Gobain is a global light-construction group that pairs local building-material platforms with a fast-growing construction-chemicals engine. 2025 delivered 46.5 billion euros of sales, a 15.5% EBITDA margin and 3.75 billion euros of free cash flow, yet Q1 2026 sales fell 2.3% like-for-like with North America down 11.3%. Rating Hold: the transformation is proven and the shares trade near 12.8x earnings against Sika at 24x, but at 74.16 EUR the price sits above the 64 EUR conservative value and the classical margin of safety is missing.
62/100
Amazon: AWS Demand and AI Commitments Are Real, but 230.86 USD Still Asks Investors to Fund a 200 Billion USD Capex Cycle Without a Margin of Safety
Amazon is a compound platform whose commerce and logistics network feeds a high-margin advertising and subscription layer, while AWS supplies the profit. 2025 revenue reached 716.9 billion USD, yet trailing free cash flow collapsed to 1.2 billion by Q1 2026 as capex climbed toward a projected 200 billion USD for the year, even as AWS reaccelerated to 28% growth. Rating Hold: the AI demand evidence is now partly contracted and real, but at 230.86 USD the stock sits about 28% above the conservative fair value of 180 USD with no margin of safety.
51/100
Fujimi: The Hidden Champion of CMP and Silicon-Wafer Polishing Materials, but 3,680 Yen Already Prepays a Good Deal of the Next Few Years
Fujimi is a Japanese precision-abrasives maker whose profit core is front-end CMP slurry and silicon-wafer polishing materials, which together approach 80% of revenue. In the fiscal year ended March 2026 it produced 69.404 billion JPY of revenue and 13.826 billion JPY of operating income, with operating margin back at 19.9%, yet the company's own estimate puts its share across all CMP steps at just 13%, with the very high shares concentrated in silicon-wafer polishing. Rating Watch: the business quality and the FEOL moat are real, but a trailing P/E near 30x already prepays the growth and leaves a thin margin of safety.
58/100
Wix.com: The Partner Channel Is Where AI Shows Up First, and 58.55 USD Prices a Permanent Erosion the Disclosed Evidence Does Not Yet Support
Wix runs a cloud platform for website creation, commerce and small-business software, monetized through recurring subscriptions plus attached payments and business tools. 2025 revenue reached 1.99 billion USD and Q1 2026 bookings still grew 15%, but non-GAAP operating margin fell to 5% from 21% and the June 8 6-K conceded a sharper-than-expected slowdown in the Partners channel. Rating Cautious Buy: at 58.55 USD the market is pricing a permanent AI-driven erosion that the disclosed evidence does not yet support.
67/100
Microsoft: Azure Demand Is Real and the Moat Is Intact, but 393 USD Already Prices a Clean Conversion of the 190 Billion USD Capex Wave
Microsoft is a cash-rich enterprise software and cloud platform whose profit pool sits in Productivity and Intelligent Cloud, and it is now funding an unprecedented AI infrastructure build. Fiscal 2025 produced 281.7 billion USD of revenue and 136.2 billion USD of operating cash flow, yet calendar-2026 capex is guided at roughly 190 billion USD and trailing free cash flow falls from 72.9 billion to 41.7 billion USD once finance leases are counted. Rating Hold: the moat and the Azure demand are real, but 393 USD already assumes that capex wave converts cleanly into owner earnings.
66/100
NVIDIA: Demand Has Broadened Beyond the Hyperscalers, but Its Funding Base Has Not, and 197 USD Already Prices Continued Excellence
NVIDIA sells accelerated-computing platforms rather than loose chips, pairing GPUs and rack-scale systems with high-speed networking, a growing CPU line and the CUDA software estate. Fiscal 2026 revenue reached 215.9 billion USD with 193.7 billion USD from Data Center, yet three direct customers accounted for 21%, 17% and 16% of Q1 FY2027 revenue and the AI buildout is leaning harder on external financing than headline growth suggests. Rating Hold: at 197.01 USD the stock is credible to own but offers no margin of safety, with the ideal buy zone at 100 to 110 USD.
49/100
Zymeworks: The Molecule Is Proven, the Allocator Is Not
Zymeworks is a biotech licensor rebuilding itself into a cash-flow aggregator: zanidatamab royalties and milestones collected through Jazz and BeOne, plus a pending Theravance acquisition that would add YUPELRI profit-share economics. The engine is real but still thin, and both of its best streams are already pledged: 30% of Ziihera royalties back a $250 million Royalty Pharma note, and 75% of YUPELRI profit share would service a $350 million OMERS note. Rating Hold: at $22.61 the shares sit inside the acceptable-hold band but above the conservative case, so investors are paying for the transition before the deal and the August 25, 2026 PDUFA resolve.
49/100
EVE Energy: Storage Now Leads the Growth and Carries the Thinnest Margin, and Capex Still Outruns the Cash It Converts
EVE Energy is a Chinese lithium-battery maker whose center of gravity has moved to grid and utility storage, already 39.8% of 2025 revenue and the largest quarterly shipment line by Q1 2026. Annual operating cash flow of CNY 7.492bn converts at about 1.81 times net profit, but CNY 10.45bn of fixed-asset spending keeps free cash flow negative, and storage carries the thinnest gross margin of the three segments at 12.28%. Rating Watch: the storage position is real, yet the price already sits above the conservative value and the ideal buy zone is 38 to 45 CNY.
48/100
T&S Communications: A Real Upstream Bottleneck, Priced as if Scarcity Economics Were Permanent
T&S Communications is an upstream optical-component supplier whose active optical components, led by 1.6T optical engines, reached 58.1% of revenue in 2025 as revenue grew 58.8% to CNY 5.16 billion with about CNY 2.02 billion of attributable net profit. The business quality is real but so is the concentration: the top five customers were 90.6% of revenue and the largest alone 63.9%. Rating Avoid: at CNY 209.19 and roughly 110 times static earnings, even the report's optimistic scenario of CNY 165 per share sits below the current price.
28/100
DENTSPLY SIRONA: A Real Dental Incumbent, but the Repricing Is Permanent and 13.02 USD Already Prices Base Value
DENTSPLY SIRONA is a broad, diversified dental supplier spanning consumables and endodontics, implants, imaging and chairside CAD/CAM equipment. Sales of 3.68 billion USD in 2025 produced free cash flow of only 104 million USD, and market value has fallen from about 11.11 billion USD at end-2016 to roughly 2.55 billion USD. Rating Watch: the discount is a permanent repricing of business quality, governance trust and category relevance rather than a cyclical dip, so at 13.02 USD the stock already trades near base value and the ideal buy zone is 7 to 9 USD.
53/100
Innovent Biologics: The China Platform Is Real, but the Price Already Pre-Pays the Obesity Curve
Innovent Biologics is a China biopharma with 18 approved products, an oncology commercial base that produced RMB11.93 billion of 2025 product revenue, and a new obesity franchise built on mazdutide. 2025 brought the first full-year profit of RMB813.6 million, but headline operating cash flow of RMB10.0 billion was flattered by a RMB7.64 billion contract-liability inflow tied to Takeda's upfront. Rating Hold: at HK$89.35 and roughly 10 times trailing sales, the price already pre-pays much of the obesity and licensing upside before the economics are proven.